AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33229039 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyalkenoic acid conditioning
Number of subjects: 6
Study 33229039 — intervention group
Group type: COMPARATOR
Intervention: No conditioning (control)
Number of subjects: 6
Study 32571399 — intervention group
Group type: EXPERIMENTAL
Intervention: Three hours of uninterrupted sitting
Number of subjects: 22
Study 32571399 — intervention group
Group type: COMPARATOR
Intervention: Regular (every 30 min) two-minute walking breaks during sitting
Number of subjects: 22
Study 32571399 — intervention group
Group type: COMPARATOR
Intervention: Higher mental activity during sitting
Number of subjects: 22
Study 36217131 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg, once daily)
Number of subjects: 99
Study 36217131 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol (160/4.5 μg, one puff, twice daily)
Number of subjects: 99
Study 36217131 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast plus budesonide/formoterol
Number of subjects: 99
Study 33944623 — intervention group
Group type: EXPERIMENTAL
Intervention: DENV-2
Number of subjects: 639
Study 33944623 — intervention group
Group type: EXPERIMENTAL
Intervention: NS1 positive sera
Number of subjects: 639
Study 33944623 — intervention group
Group type: EXPERIMENTAL
Intervention: DENV-1
Number of subjects: 639
Study 33944623 — intervention group
Group type: EXPERIMENTAL
Intervention: DENV-3
Number of subjects: 639
Study 33944623 — intervention group
Group type: EXPERIMENTAL
Intervention: DENV-4
Number of subjects: 639
Study 33944623 — intervention group
Group type: EXPERIMENTAL
Intervention: ZIKV
Number of subjects: 639
Study 33944623 — intervention group
Group type: COMPARATOR
Intervention: DENV-2, DENV-3, ZIKV
Number of subjects: 639
Study 33944623 — intervention group
Group type: EXPERIMENTAL
Intervention: Aedes aegypti
Number of subjects: 639
Study 32453453 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure reduction with intravenous nicardipine
Number of subjects: 913
Study 33685268 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with standard-of-care (SOC)
Number of subjects: 81
Study 33685268 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (SOC) only
Number of subjects: 81
Study 34314516 — intervention group
Group type: EXPERIMENTAL
Intervention: CAPABLE program (10-session, home-based interprofessional program)
Number of subjects: 1144
Study 34314516 — intervention group
Group type: EXPERIMENTAL
Intervention: CAPABLE program (full-tested dose)
Number of subjects: 1144
Study 34314516 — intervention group
Group type: EXPERIMENTAL
Intervention: CAPABLE program (cost analysis)
Number of subjects: 1144
Study 34314516 — intervention group
Group type: EXPERIMENTAL
Intervention: CAPABLE program (decreased dose)
Number of subjects: 1144
Study 32592516 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive vagus nerve stimulation (nVNS)
Number of subjects: 23
Study 32592516 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 23
Study 36051935 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness combined with aerobic exercise (MMAE)
Number of subjects: 120
Study 36051935 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness meditation (MM)
Number of subjects: 120
Study 36051935 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise (AE)
Number of subjects: 120
Study 33801485 — intervention group
Group type: COMPARATOR
Intervention: Various lifestyle interventions (diet, activity, sleep, emotion regulation, parenting education)
Number of subjects: 29
Study 33801485 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 29
Study 34203033 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant-based protein product (FP)
Number of subjects: 0
Study 34203033 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 36152686 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent positive pressure ventilation via face mask and T piece from 20 to 50 seconds of age with a fractional inspired oxygen of 0.3
Number of subjects: 113
Study 36152686 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (gentle stimulation in a neutral position for 50 seconds)
Number of subjects: 113
Study 36152686 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (breathing support)
Number of subjects: 113
Study 36152686 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 113
Study 33637001 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (SSRI)
Number of subjects: 601
Study 33637001 — intervention group
Group type: COMPARATOR
Intervention: Reboxetine (noradrenaline reuptake inhibitor)
Number of subjects: 601
Study 33637001 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram and Reboxetine (irrespective of class)
Number of subjects: 601
Study 34607470 — intervention group
Group type: EXPERIMENTAL
Intervention: Effortful swallowing
Number of subjects: 15
Study 33875726 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous renal puncture guided by 3D visualization fused with ultrasound
Number of subjects: 118
Study 33875726 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous renal puncture guided by B-ultrasonography (B-US)
Number of subjects: 118
Study 35473648 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia Coach (n = 25)
Number of subjects: 50
Study 35473648 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (n = 25)
Number of subjects: 50
Study 32044999 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg daily)
Number of subjects: 52
Study 32044999 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 35276309 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (cathodal stimulation over the left DLPFC)
Number of subjects: 29
Study 35276309 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 29
Study 35412211 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-guided celiac plexus neurolysis (EUS-CPN) plus EUS-guided celiac ganglia neurolysis (EUS-CGN)
Number of subjects: 51
Study 35412211 — intervention group
Group type: COMPARATOR
Intervention: EUS-guided celiac plexus neurolysis (EUS-CPN) alone
Number of subjects: 51
Study 34456565 — intervention group
Group type: EXPERIMENTAL
Intervention: SPSRS application (positive word stimulus in a 10-minute video)
Number of subjects: 32
Study 34456565 — intervention group
Group type: COMPARATOR
Intervention: YouTube application (without positive word stimulus in 10-minute video)
Number of subjects: 32
Study 35766283 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (a‐tDCS, 2 mA for 20 min)
Number of subjects: 8
Study 35766283 — intervention group
Group type: COMPARATOR
Intervention: Sham-tDCS (placebo)
Number of subjects: 8
Study 34462283 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient decision aid for subacromial decompression surgery and rotator cuff repair surgery
Number of subjects: 40
Study 34462283 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient decision aid
Number of subjects: 40
Study 32442020 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab treatment
Number of subjects: 93
Study 36410442 — intervention group
Group type: EXPERIMENTAL
Intervention: Native vessel PCI
Number of subjects: 584
Study 36410442 — intervention group
Group type: COMPARATOR
Intervention: SVG PCI
Number of subjects: 584
Study 34433118 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (3 times/week for 8 weeks at 60 - 70% of VO2max + home exercises)
Number of subjects: 38
Study 34433118 — intervention group
Group type: COMPARATOR
Intervention: Control group (home exercises program 3 times a week for 8 weeks)
Number of subjects: 38
Study 34433118 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 38
Study 32371517 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of care managers for patients with depression
Number of subjects: 497
Study 34989648 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (aerobic/resistance 3 times/week, starting at ∼13th gestation week until birth)
Number of subjects: 80
Study 34989648 — intervention group
Group type: COMPARATOR
Intervention: Combined groups (exercise and control)
Number of subjects: 80
Study 33462913 — intervention group
Group type: EXPERIMENTAL
Intervention: Model including families' physical/mental health status and preparedness toward bereavement
Number of subjects: 17312
Study 32353052 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-automated measurements of ellipsoid zone (EZ) defect area
Number of subjects: 75
Study 32353052 — intervention group
Group type: COMPARATOR
Intervention: Manual measurements of ellipsoid zone (EZ) defect area
Number of subjects: 75
Study 32353052 — intervention group
Group type: COMPARATOR
Intervention: Comparison of semi-automated and manual measurements
Number of subjects: 75
Study 36332823 — intervention group
Group type: EXPERIMENTAL
Intervention: Analog insulin
Number of subjects: 102
Study 36332823 — intervention group
Group type: COMPARATOR
Intervention: Human insulin
Number of subjects: 102
Study 33852173 — intervention group
Group type: EXPERIMENTAL
Intervention: GIP injection
Number of subjects: 11
Study 33852173 — intervention group
Group type: COMPARATOR
Intervention: GLP-2 injection
Number of subjects: 11
Study 35400136 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic osteochondroplasty
Number of subjects: 214
Study 35400136 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic lavage
Number of subjects: 214
Study 32091925 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 12647
Study 32091925 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 12647
Study 35868987 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling at 55 % of maximal aerobic power
Number of subjects: 28
Study 35868987 — intervention group
Group type: COMPARATOR
Intervention: Running at 55 % of maximal oxygen uptake
Number of subjects: 28
Study 35868987 — intervention group
Group type: COMPARATOR
Intervention: Running
Number of subjects: 28
Study 35868987 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling
Number of subjects: 28
Study 34327591 — intervention group
Group type: EXPERIMENTAL
Intervention: DCE-CT-derived blood volume (BVdeconv > median)
Number of subjects: 25
Study 34327591 — intervention group
Group type: EXPERIMENTAL
Intervention: DCE-CT-derived blood volume (BVPatlak > median)
Number of subjects: 25
Study 34327591 — intervention group
Group type: EXPERIMENTAL
Intervention: DCE-CT-derived blood flow (BFdeconv > median)
Number of subjects: 25
Study 34327591 — intervention group
Group type: COMPARATOR
Intervention: CD34-indexT > median
Number of subjects: 25
Study 34327591 — intervention group
Group type: COMPARATOR
Intervention: CD34-indexTN > median
Number of subjects: 25
Study 35202621 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (10 mg/kg) three times weekly for 3 months along with standard treatment
Number of subjects: 120
Study 35202621 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 120
Study 35202621 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin group
Number of subjects: 120
Study 35202621 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 35368935 — intervention group
Group type: EXPERIMENTAL
Intervention: Qili Qiangxin capsule combined with sacubitril and valsartan
Number of subjects: 108
Study 33547263 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling power training (CPT, n = 8)
Number of subjects: 20
Study 33547263 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance power training (RPT, n = 10)
Number of subjects: 20
Study 32276613 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone calls
Number of subjects: 11880
Study 32276613 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS reminders
Number of subjects: 11880
Study 32276613 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 11880
Study 616670506 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 47
Study 616670506 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 34973228 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately hypofractionated radiotherapy
Number of subjects: 0
Study 34973228 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafractionation (five fractions)
Number of subjects: 0
Study 33973141 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergame training and exercise program (EEP)
Number of subjects: 19
Study 33973141 — intervention group
Group type: COMPARATOR
Intervention: Conventional exercise program (CEP)
Number of subjects: 19
Study 34127003 — intervention group
Group type: EXPERIMENTAL
Intervention: PDE
Number of subjects: 35
Study 34127003 — intervention group
Group type: COMPARATOR
Intervention: RME30
Number of subjects: 35
Study 34127003 — intervention group
Group type: COMPARATOR
Intervention: RME100
Number of subjects: 35
Study 32272260 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BR) 210 mL (18.6 mmol NO3‐)
Number of subjects: 10
Study 32272260 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BR)
Number of subjects: 10
Study 32272260 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL) (0.12 mmol NO3‐)
Number of subjects: 10
Study 35977072 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2409021 (100 mg single dose)
Number of subjects: 20
Study 35977072 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 32939849 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sildenafil therapy (administered two weeks before surgery)
Number of subjects: 30
Study 36344940 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg orally twice daily for 52 weeks
Number of subjects: 119
Study 36344940 — intervention group
Group type: COMPARATOR
Intervention: Placebo 600 mg orally twice daily for 52 weeks
Number of subjects: 119
Study 36344940 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 119
Study 36344940 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 33198715 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education intervention for 6 months
Number of subjects: 652
Study 33198715 — intervention group
Group type: COMPARATOR
Intervention: Control group (no education)
Number of subjects: 652
Study 34738855 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (30 mg/day for one week, then titrated to 60 mg/day for 12 weeks)
Number of subjects: 40
Study 34738855 — intervention group
Group type: COMPARATOR
Intervention: Placebo (one capsule daily for one week, then two capsules daily for 12 weeks)
Number of subjects: 40
Study 33675614 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring (VR) for HIV prevention
Number of subjects: 96
Study 32234329 — intervention group
Group type: EXPERIMENTAL
Intervention: Volixibat (5, 10 or 20 mg)
Number of subjects: 197
Study 32234329 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study 32234329 — intervention group
Group type: EXPERIMENTAL
Intervention: Volixibat (any dose)
Number of subjects: 197
Study 32234329 — intervention group
Group type: EXPERIMENTAL
Intervention: Volixibat
Number of subjects: 197
Study 36496272 — intervention group
Group type: EXPERIMENTAL
Intervention: Counterconditioning (pairing CS+ with pleasant pictures)
Number of subjects: 175
Study 36496272 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure (repeated presentation of CS‐only trials)
Number of subjects: 175
Study 36496272 — intervention group
Group type: EXPERIMENTAL
Intervention: US revaluation (pairing disgusting US with pleasant pictures)
Number of subjects: 175
Study 36496272 — intervention group
Group type: COMPARATOR
Intervention: Control (filler task)
Number of subjects: 175
Study 33784020 — intervention group
Group type: EXPERIMENTAL
Intervention: Botox 100 U
Number of subjects: 176
Study 33784020 — intervention group
Group type: EXPERIMENTAL
Intervention: Botox 50 U
Number of subjects: 176
Study 33784020 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 176
Study 34423919 — intervention group
Group type: EXPERIMENTAL
Intervention: PF-06650833
Number of subjects: 0
Study 32289696 — intervention group
Group type: EXPERIMENTAL
Intervention: cathodal tDCS (c‐tDCS) 22 sessions (20min/1000 μA)
Number of subjects: 45
Study 32289696 — intervention group
Group type: COMPARATOR
Intervention: sham intervention
Number of subjects: 45
Study 35246766 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation and Training Group (TGPBM)
Number of subjects: 0
Study 35246766 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation Group (GPBM)
Number of subjects: 0
Study 35246766 — intervention group
Group type: COMPARATOR
Intervention: Placebo Photobiomodulation and Training Group (TGPLA)
Number of subjects: 0
Study 35246766 — intervention group
Group type: COMPARATOR
Intervention: Comparison between TGPBM and TGPLA
Number of subjects: 0
Study 35246766 — intervention group
Group type: COMPARATOR
Intervention: Comparison between TGPBM and GPBM
Number of subjects: 0
Study 34028826 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (one capsule/day for 30 days)
Number of subjects: 48
Study 34028826 — intervention group
Group type: COMPARATOR
Intervention: Placebo (one capsule/day for 30 days)
Number of subjects: 48
Study 34450396 — intervention group
Group type: EXPERIMENTAL
Intervention: High level of physical activity
Number of subjects: 492
Study 34450396 — intervention group
Group type: COMPARATOR
Intervention: Low-moderate level of physical activity
Number of subjects: 492
Study 35790574 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (HUMIRA) injection
Number of subjects: 93
Study 33622269 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated multidisciplinary rehabilitation programme
Number of subjects: 190
Study 33622269 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 190
Study 33125390 — intervention group
Group type: EXPERIMENTAL
Intervention: Xpert HIV-1 Qual assay (near point-of-care EID testing)
Number of subjects: 23
Study 33125390 — intervention group
Group type: COMPARATOR
Intervention: Standard of care tests (centralized laboratory-based testing)
Number of subjects: 23
Study 35147466 — intervention group
Group type: EXPERIMENTAL
Intervention: Bremelanotide
Number of subjects: 3500
Study 35147466 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3500
Study 33754338 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal scalp blood sampling for lactate measurement (FBSLM) in addition to CTG monitoring
Number of subjects: 123
Study 33754338 — intervention group
Group type: COMPARATOR
Intervention: CTG without FBS
Number of subjects: 123
Study 32102728 — intervention group
Group type: EXPERIMENTAL
Intervention: Actively induced medical rehabilitation (112 patients underwent rehabilitation)
Number of subjects: 431
Study 32102728 — intervention group
Group type: COMPARATOR
Intervention: Routine care (15 patients underwent rehabilitation)
Number of subjects: 431
Study 32102728 — intervention group
Group type: EXPERIMENTAL
Intervention: Actively induced medical rehabilitation
Number of subjects: 431
Study 32102728 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 431
Study 36181044 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical and scapula-focused resistance exercise group (CSREG)
Number of subjects: 41
Study 36181044 — intervention group
Group type: COMPARATOR
Intervention: Trapezius massage group (TMG)
Number of subjects: 41
Study 36181044 — intervention group
Group type: COMPARATOR
Intervention: Comparison between CSREG and TMG
Number of subjects: 41
Study 33906652 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 °C irrigation fluid
Number of subjects: 108
Study 33906652 — intervention group
Group type: EXPERIMENTAL
Intervention: 27 °C irrigation fluid
Number of subjects: 108
Study 33906652 — intervention group
Group type: EXPERIMENTAL
Intervention: 37 °C irrigation fluid
Number of subjects: 108
Study 35102782 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTX)
Number of subjects: 54
Study 35102782 — intervention group
Group type: COMPARATOR
Intervention: Minimal acupuncture (ACU)
Number of subjects: 54
Study 35333618 — intervention group
Group type: EXPERIMENTAL
Intervention: Maybe Later Baby (MLB) alone
Number of subjects: 23
Study 35333618 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented intervention (MLB + consultation with health care professional)
Number of subjects: 23
Study 35333618 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 23
Study 34751662 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT-based smartphone intervention (iCanQuit)
Number of subjects: 2415
Study 34751662 — intervention group
Group type: COMPARATOR
Intervention: Comparison smartphone intervention (QuitGuide)
Number of subjects: 2415
Study 32236675 — intervention group
Group type: EXPERIMENTAL
Intervention: DCB angioplasty
Number of subjects: 171
Study 32236675 — intervention group
Group type: COMPARATOR
Intervention: Plain old balloon angioplasty
Number of subjects: 171
Study 33212337 — intervention group
Group type: EXPERIMENTAL
Intervention: Active images of models presented in active stances
Number of subjects: 122
Study 33212337 — intervention group
Group type: COMPARATOR
Intervention: Posed images of models
Number of subjects: 122
Study 33212337 — intervention group
Group type: COMPARATOR
Intervention: Images of scenery
Number of subjects: 122
Study 32087422 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Misgav Ladach (ML) technique
Number of subjects: 822
Study 32087422 — intervention group
Group type: COMPARATOR
Intervention: Dörffler (Pfannenstiel - Kerr) method
Number of subjects: 822
Study 36399114 — intervention group
Group type: EXPERIMENTAL
Intervention: 60EX (exercise session 60 minutes post-meal)
Number of subjects: 13
Study 36399114 — intervention group
Group type: EXPERIMENTAL
Intervention: 120EX (exercise session 120 minutes post-meal)
Number of subjects: 13
Study 36399114 — intervention group
Group type: EXPERIMENTAL
Intervention: 60EX
Number of subjects: 13
Study 36399114 — intervention group
Group type: EXPERIMENTAL
Intervention: 120EX
Number of subjects: 13
Study 36399114 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 13
Study 34134777 — intervention group
Group type: EXPERIMENTAL
Intervention: Avmacol® (broccoli seed and sprout extracts)
Number of subjects: 0